Literature DB >> 7691155

Tissue culture loss of aneuploid cells from carcinomas of the prostate.

J J König1, W Teubel, J W van Dongen, A Hagemeijer, J C Romijn, F H Schröder.   

Abstract

The frequency of aneuploid cells in cultured prostate carcinoma specimens was investigated. Ploidy distribution of the original tissue was established by flow cytometry (FCM). Fluorescence in situ hybridization (FISH) of chromosome I was applied to directly isolated and cultured cells to investigate whether any modifications in the ploidy distribution of chromosome I took place during tissue culture. In six tumor specimens that were diploid by FCM and FISH, no differences were found in the ploidy distribution of chromosome I before and after tissue culture. In eight tumors that were aneuploid by FISH, the percentage of aneuploid nuclei was significantly reduced from 28.0 +/- 15.0 (range 13-59%) in uncultured cells to 9.1 +/- 4.4 (range 4-18%) after tissue culture. The reduction of aneuploid nuclei ranged from 44 to 85%, which means that the majority of the aneuploid cell populations that were observed in the original specimens were undetectable in cultured samples. This suggests a preferential growth of normal epithelial cells. The data presented can explain the high percentage of diploid karyotypes usually found in short-term cultured prostate carcinoma specimens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691155     DOI: 10.1002/gcc.2870080105

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping.

Authors:  B Beheshti; J Karaskova; P C Park; J A Squire; B G Beatty
Journal:  Mol Diagn       Date:  2000-03

Review 2.  Methods of molecular analysis: assessing losses and gains in tumours.

Authors:  R Roylance
Journal:  Mol Pathol       Date:  2002-02

3.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Allelic loss detected on chromosomes 8, 10, and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors.

Authors:  D A Deubler; B J Williams; X L Zhu; M R Steele; L R Rohr; J C Jensen; R A Stephenson; J E Changus; G J Miller; M J Becich; A R Brothman
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

5.  [From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].

Authors:  M Saar; J Kamradt; V Jung; M Stöckle; G Unteregger
Journal:  Urologe A       Date:  2011-08       Impact factor: 0.639

6.  Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

Authors:  M M Mueller; W Peter; M Mappes; A Huelsen; H Steinbauer; P Boukamp; M Vaccariello; J Garlick; N E Fusenig
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 7.  Prostate cancer progression. Implications of histopathology.

Authors:  J L Ware
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

8.  Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations.

Authors:  S Xiao; A Renshaw; E S Cibas; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.